InicioLH • NYSE
add
LabCorp
239,67 $
Después del cierre:(0,00 %)0,00
239,67 $
Cerrados: 22 nov, 16:30:01 GMT-5 · USD · NYSE · Renuncia de responsabilidad
Cierre anterior
240,17 $
Intervalo diario
238,82 $ - 240,97 $
Intervalo anual
191,97 $ - 247,99 $
Cap. bursátil
20,05 mil M USD
Volumen medio
702,29 mil
Relación precio-beneficio
46,45
Rentabilidad por dividendo
1,20 %
Bolsa de valores principal
NYSE
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(USD) | sept 2024info | Cambio interanual |
---|---|---|
Ingresos | 3282,00 M | 7,37 % |
Gastos operativos | 632,30 M | 8,79 % |
Ingresos netos | 169,30 M | -7,64 % |
Margen de beneficio neto | 5,16 | -14,00 % |
Beneficios por acción | 3,50 | 3,55 % |
EBITDA | 433,60 M | 4,26 % |
Tipo impositivo efectivo | 19,47 % | — |
Balance general
Activos totales
Responsabilidades totales
(USD) | sept 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 1517,30 M | 108,45 % |
Activos totales | 18,61 mil M | 10,22 % |
Responsabilidades totales | 10,43 mil M | 15,94 % |
Patrimonio total | 8185,40 M | — |
Acciones en circulación | 83,64 M | — |
Precio-valor contable | 2,46 | — |
Rentabilidad económica | 3,85 % | — |
Retorno sobre capital | 4,53 % | — |
Flujo de caja
Variación neta del flujo de caja
(USD) | sept 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 169,30 M | -7,64 % |
Efectivo de operaciones | 277,30 M | -27,96 % |
Efectivo de inversión | -579,10 M | -18,77 % |
Efectivo de financiación | 1548,30 M | 241,11 % |
Variación neta del flujo de caja | 1252,20 M | 204,12 % |
Flujo de caja libre | 62,96 M | -61,33 % |
Información sobre la empresa
Laboratory Corporation of America Holdings, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of the division's revenue are from Medicare.
Its Biopharma Laboratory Services segment provides drug development, medical device and diagnostic development services to pharmaceutical, biotechnology, medical device, and diagnostic companies. Wikipedia
Director ejecutivo
Fundación
1978
Sitio web
Empleados
61.975